(Q48559584)

12 February 2018

title

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens (English)

1 reference

12 February 2018

1 reference

1

1 reference

12 February 2018

author name string

D Robertson

2

1 reference

12 February 2018

C T Molta

3

1 reference

12 February 2018

B Freundlich

4

1 reference

12 February 2018

R Pedersen

5

1 reference

12 February 2018

W Li

6

1 reference

12 February 2018

R Boggs

7

1 reference

12 February 2018

A S Zbrozek

8

1 reference

12 February 2018

publication date

31 October 2011

1 reference

12 February 2018

Journal of the European Academy of Dermatology and Venereology

published in

1 reference

12 February 2018

volume

26

1 reference

12 February 2018

issue

11

1 reference

12 February 2018

page(s)

1436-1443

1 reference

12 February 2018

Psoriatic arthritis: therapeutic principles

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

21 January 2018

Psoriasis comorbidities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Psoriasis and sex: a study of moderately to severely affected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Treatment recommendations for psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Treatment goals in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Statistical versus quantitative significance in the socioeconomic evaluation of medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Measuring disability and quality of life in established rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

Patient-reported outcomes and their role in the assessment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04308.X

10.1111/J.1468-3083.2011.04308.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

release_pjq5b7hai5g7jbvqu7ueipxusi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pjq5b7hai5g7jbvqu7ueipxusi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 February 2018